Loading...

Qilian International Holding Group Limited

QLINASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$5.41
$-0.20(-3.57%)

Qilian International Holding Group Limited (QLI) Stock Overview

Explore Qilian International Holding Group Limited’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B

Score: 62.2/100

Key Financials

Market Cap38.7M
P/E Ratio-24.86
EPS (TTM)$-1.10
ROE-0.16%
Fundamental Analysis

AI Price Forecasts

1 WeekN/A
1 MonthN/A
3 MonthsN/A
1 Year Target$3.47

QLI Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Qilian International Holding Group Limited (QLI) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $3.47.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -24.86 and a market capitalization of 38.7M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;